top of page

INSULIN GLARGINE, HUMAN

Brand Name :

(Lantus) ®

Dosage form :

Injection 100 units/ml SC; cartridge

Indication :

Treatment of insulin-dependent diabetes mellitus, also non-insulin-
dependent diabetes mellitus unresponsive to treatment with diet
and/or oral hypoglycemics.

Dosage :

Type 2 diabetes (patient not already on insulin): 10 units once daily,
adjusted according to patient response (2-100 units daily).
Patients already receiving insulin: in clinical studies, when chaging to
insulin glargine from once-daily NPH, the initial dose was not
changed; when changing from twice-daily NPH to once-daily insulin
glargine, the total dailly dose was reduced by 20% and adjusted
according to patient response.

Warning / precaution :

Adverse reactions :

Palpitation, fatigue, mental confusion.

Therapeutic class :

Medication safety issues :

bottom of page